T2 Biosystems, Inc. (NASDAQ:TTOO – Get Free Report) passed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $0.01 and traded as high as $0.0115. T2 Biosystems shares last traded at $0.0110, with a volume of 34,136 shares changing hands.
T2 Biosystems Stock Performance
The company’s 50 day moving average price is $0.01 and its 200-day moving average price is $0.04. The company has a market cap of $231,473.00, a price-to-earnings ratio of 0.00 and a beta of 0.73.
About T2 Biosystems
T2 Biosystems, Inc is a commercial‐stage diagnostics company focused on developing and marketing innovative, rapid diagnostic products designed to improve patient outcomes and reduce healthcare costs. The company’s proprietary T2 Magnetic Resonance (T2MR) technology enables direct detection of pathogens and biomarkers in whole blood without the need for culture, delivering results in hours rather than days. T2 Biosystems’ core mission is to provide clinicians with faster, actionable data to guide treatment decisions, particularly in the management of sepsis, bloodstream infections and other life‐threatening conditions.
The flagship product, the T2Dx® Instrument, serves as the platform for all T2 assays.
Further Reading
- Five stocks we like better than T2 Biosystems
- Wall Street Stockpicker Names #1 Stock of 2026
- The Best $1 You’ll Spend This Holiday Season
- ALERT: Drop these 5 stocks before January 2026!
- The $650 Million Bet on AI’s Future
- Nvidia x 1,000,000
Receive News & Ratings for T2 Biosystems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for T2 Biosystems and related companies with MarketBeat.com's FREE daily email newsletter.
